The ELVESYS Microfluidic Innovation Center® works with the DGA (Direction générale de l’armement) to develop outstanding pathogenic detection systems in order to ensure the protection of soldiers during military operations and of civilian targets against bioterrorism. Using our patented microfluidic technologies and in collaboration with the Ecole Normale Supérieure of Paris, we are developing an operational demonstrator that enables large scale pathogenic detection in less than 10 minutes.
“This multidisciplinary collaboration focuses on four main technologies”
Second generation electrophoresis systems for the tunable separation of pre-concentrate samples before analysis. This project relies on a collaboration between Elvesys and the CNRS in order to provide an efficient and universal microfluidic separation device for medical applications.
A microstructured membrane system designed to wash biological samples before analysis. This project was initiated by a collaboration with the CFI and continues through a European consortium.
Ultrafast detection of viruses and bacteria in food / air / blood. This technology was developed in collaboration with the DGA and was awarded the global innovation award by the French government.
Application of nanofluidics to proteomics. This project relies on a collaboration between Elvesys, the DGA and the CNRS and uses new physical effects discoverd by our team at the nanoscale which provide a system that will enable the separation and pre-concentration of any molecules of interest by a factor 1000 in mere minutes .
Leader, partner, subcontractor…Whatever your role in the revolution of lab on a chip systems, feel free to contact us to learn more about how to advance in microfluidic technologies and accelerate the transfer of cutting edge technologies to the market.